AB Science S.A. (ABSCF)
OTCMKTS
· Delayed Price · Currency is USD
1.570
+0.670 (74.44%)
At close: Feb 13, 2025
AB Science Revenue
AB Science had revenue of 560.00K EUR in the half year ending June 30, 2024, a decrease of -10.97%. This brings the company's revenue in the last twelve months to 1.08M, up 39.25% year-over-year. In the year 2023, AB Science had annual revenue of 970.00K with 1.25% growth.
Revenue (ttm)
1.08M EUR
Revenue Growth
+39.25%
P/S Ratio
94.20
Revenue / Employee
18.98K EUR
Employees
57
Market Cap
109.20M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 970.00K | 12.00K | 1.25% |
Dec 31, 2022 | 958.00K | -649.00K | -40.39% |
Dec 31, 2021 | 1.61M | 24.00K | 1.52% |
Dec 31, 2020 | 1.58M | 12.00K | 0.76% |
Dec 31, 2019 | 1.57M | -130.00K | -7.64% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
SS Innovations International | 20.65M |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |